Business
Up 36% in a year, why this $8 billion ASX 200 stock has still a ‘strong growth forecast’
Image source: Getty Images
Looking for a quality, under-the-radar S&P/ASX 200 Index (ASX: XJO) stock with strong forecast revenue growth?
Then you may want to check out Telix Pharmaceuticals Ltd (ASX: TLX).
Shares in the diagnostic and therapeutic product developer closed on Friday trading for…
Continue Reading
-
Noosa News23 hours agoWounding investigation, Mooloolaba – Sunshine Coast
-
General22 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
Business19 hours agoCan the Xero share price deliver a 17% return after the US acquisition?
-
Noosa News18 hours agoTwo people charged after Mooloolaba stabbing